Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | HPGD | P15428 | 3/20 | 0.32 |
| ▸ | MAPT | P10636 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20735375 | 0.91 | NPC1 (0.32) | NPC1RAB9A | |
| SCHEMBL22037171 | 0.79 | NPC1 (0.33) | NPC1RAB9AALDH1A1POLBHSD17B10 | |
| SCHEMBL20735396 | 0.77 | FLT3 (0.37) | NPC1RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL21264693 | 0.75 | — | — | |
| SCHEMBL24379795 | 0.74 | NPC1 (0.43) | NPC1RAB9A | |
| SCHEMBL20735542 | 0.72 | NPC1 (0.33) | NPC1RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL20697969 | 0.69 | FLT3 (0.36) | NPC1RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL24379793 | 0.67 | NPC1 (0.34) | NPC1RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL22037061 | 0.67 | RAB9A (0.41) | NPC1RAB9AKDM4EALDH1A1HPGD | |
| SCHEMBL18701469 | 0.66 | NPC1 (0.43) | NPC1RAB9AKDM4EALDH1A1HPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11349083-B2 | Organic electroluminescent materials and devices | UNIVERSAL DISPLAY CORPORATION (US) | 2022-05-31 | — | — | US | disclosed |
| US-20190051843-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION | 2019-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20190051843-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | BMP4, CTCF, ORC3 | NPC1 4425/4885RAB9A 3064/4885KDM4E 1387/4885 |
| US-11349083-B2 | Organic electroluminescent materials and devices | BMP4, CTCF, ORC3 | NPC1 4425/4885RAB9A 3064/4885KDM4E 1387/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.